Stifel Nicolaus Keeps Their Buy Rating on Turtle Beach (HEAR)
In a report released today, Drew Crum from Stifel Nicolaus maintained a Buy rating on Turtle Beach (HEAR – Research Report), with a price ...
Business Insider3d
Stifel Nicolaus Remains a Hold on Revance Therapeutics (RVNC)
In a report released today, Annabel Samimy from Stifel Nicolaus maintained a Hold rating on Revance Therapeutics (RVNC – Research Report), with a price target of $6.66. The company’s shares ...